Brevan Howard Capital Management’s Ultragenyx Pharmaceutical RARE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $297K | Buy |
+8,161
| New | +$297K | ﹤0.01% | 1467 |
|
|
2025
Q1 | – | Sell |
-35,201
| Closed | -$1.48M | – | 1352 |
|
|
2024
Q4 | $1.48M | Buy |
35,201
+18,960
| +117% | +$798K | 0.01% | 315 |
|
|
2024
Q3 | $902K | Buy |
+16,241
| New | +$902K | 0.01% | 431 |
|
|
2024
Q2 | – | Sell |
-9,077
| Closed | -$424K | – | 1291 |
|
|
2024
Q1 | $424K | Buy |
+9,077
| New | +$424K | ﹤0.01% | 465 |
|